0000899243-22-017890.txt : 20220512 0000899243-22-017890.hdr.sgml : 20220512 20220512211859 ACCESSION NUMBER: 0000899243-22-017890 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220510 FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carson Seana CENTRAL INDEX KEY: 0001923756 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 22919912 MAIL ADDRESS: STREET 1: 400 SOMERSET CORPORATE BLVD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-10 0 0000885590 Bausch Health Companies Inc. BHC 0001923756 Carson Seana 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER 08807 0 1 0 0 EVP, General Counsel Common Shares, No Par Value 2022-05-10 4 M 0 2752 A 71322 D Common Shares, No Par Value 2022-05-10 4 M 0 4715 A 76037 D Restricted Share Units 2022-05-10 4 A 0 2752 A 2022-05-10 Common Shares, No Par Value 2752 0 D Restricted Share Units 2022-05-10 4 M 0 2752 9.40 D 2022-05-10 Common Shares, No Par Value 0 0 D Restricted Share Units 2022-05-10 4 A 0 4715 A 2022-05-10 Common Shares, No Par Value 4715 0 D Restricted Share Units 2022-05-10 4 M 0 4715 9.40 D 2022-05-10 Common Shares, No Par Value 0 0 D Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service. Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service. Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis. /s/ Brianna M. Cetrulo, attorney-in-fact 2022-05-12